SCHEMBL18154443

SCHEMBL18154443

C[S+]([O-])c1ccc(Br)cc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 3/20 0.39
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
PTPRC P08575 1/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
GLA P06280 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
GABRA1 P14867 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25905318 0.87 PTPRC (0.42) PTGDR2ALDH1A1MAPK1AKR1C3AKR1C2
SCHEMBL18927764 0.86 ALDH1A1 (0.33) PTGDR2ALDH1A1MAPK1LMNAKDM4E
SCHEMBL18073805 0.86 ALDH1A1 (0.39) PTGDR2ALDH1A1MAPK1AKR1C3AKR1C2
SCHEMBL22195540 0.82 GABRP (0.38) ALDH1A1LMNATP53MAPTGABRA1
SCHEMBL25893309 0.80 PTGS2 (0.42) ALDH1A1NPC1RAB9APTPRCLMNA
SCHEMBL18154498 0.79 PTPRC (0.37) ALDH1A1MAPK1NPC1TSHRRAB9A
SCHEMBL18927797 0.79 ALDH1A1 (0.34) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL22195510 0.78 SMN1; SMN2 (0.39) MAPK1TSHRPTPRCMAPTGABRA1
SCHEMBL18927766 0.78 ALDH1A1 (0.37) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL19429151 0.77 PTGS2 (0.41) ALDH1A1MAPK1HPGDTDP1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12268086-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2025-04-01 US disclosed
CN-107531684-B Compound for organic electric element, organic electric element using same, and electronic device using same 德山新勒克斯有限公司 2020-11-24 CN disclosed
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed
CN-107531684-A Organic electric element compound, organic electric element and its electronic installation using it 德山新勒克斯有限公司 2018-01-02 CN disclosed
WO-2016167491-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS 덕산네오룩스 주식회사 2016-10-20 WO disclosed
WO-2016167491-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS 덕산네오룩스 주식회사 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12268086-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, LEF1 PTGDR2 4561/4885ALDH1A1 493/4885MAPK1 108/4885
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 PTGDR2 4561/4885ALDH1A1 493/4885MAPK1 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.